News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,176 Results
Type
Article (78821)
Company Profile (726)
Press Release (766609)
Multimedia
Podcasts (190)
Webinars (29)
Section
Business (228467)
Career Advice (3862)
Deals (39392)
Drug Delivery (151)
Drug Development (89760)
Employer Resources (205)
FDA (18131)
Job Trends (17255)
News (389621)
Policy (39005)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3014)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (153)
Alliances (56282)
ALS (183)
Alzheimer's disease (1806)
Antibody-drug conjugate (ADC) (353)
Approvals (18315)
Artificial intelligence (599)
Autoimmune disease (174)
Automation (40)
Bankruptcy (404)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (205)
Biotechnology (447)
Bladder cancer (164)
Brain cancer (66)
Breast cancer (670)
Cancer (5100)
Cardiovascular disease (453)
Career advice (3317)
Career pathing (41)
CAR-T (311)
CDC (59)
Celiac Disease (2)
Cell therapy (833)
Cervical cancer (38)
Clinical research (75832)
Collaboration (1868)
Company closure (4)
Compensation (1190)
Complete response letters (74)
COVID-19 (2995)
CRISPR (99)
C-suite (902)
Cystic fibrosis (155)
Data (6381)
Decentralized trials (2)
Denatured (69)
Depression (152)
Diabetes (540)
Diagnostics (7250)
Digital health (49)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (290)
Drug pricing (226)
Drug shortages (36)
Duchenne muscular dystrophy (246)
Earnings (97553)
Editorial (66)
Employer branding (25)
Employer resources (174)
Events (134311)
Executive appointments (1044)
FDA (21367)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1574)
Gene editing (218)
Generative AI (56)
Gene therapy (679)
GLP-1 (1142)
Government (5425)
Grass and pollen (8)
Guidances (387)
Healthcare (20945)
HIV (66)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (300)
Immuno-oncology (65)
Indications (109)
Infectious disease (3289)
Inflammatory bowel disease (207)
Inflation Reduction Act (17)
Influenza (124)
Intellectual property (254)
Interviews (761)
IPO (17870)
IRA (60)
Job creations (5023)
Job search strategy (2671)
JPM (71)
Kidney cancer (16)
Labor market (95)
Layoffs (656)
Leadership (40)
Legal (9977)
Liver cancer (99)
Longevity (15)
Lung cancer (688)
Lymphoma (385)
Machine learning (44)
Management (66)
Manufacturing (870)
MASH (177)
Medical device (15032)
Medtech (15089)
Mergers & acquisitions (22606)
Metabolic disorders (1428)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (363)
Neuropsychiatric disorders (104)
Neuroscience (3153)
Neurotech (1)
NextGen: Class of 2026 (7665)
Non-profit (5113)
Now hiring (68)
Obesity (696)
Opinion (337)
Ovarian cancer (170)
Pain (218)
Pancreatic cancer (235)
Parkinson's disease (301)
Partnered (36)
Patents (515)
Patient recruitment (504)
Peanut (61)
People (65882)
Pharmaceutical (134)
Pharmacy benefit managers (33)
Phase 1 (23484)
Phase 2 (33042)
Phase 3 (24889)
Pipeline (5373)
Policy (340)
Postmarket research (3283)
Preclinical (10372)
Press Release (72)
Prostate cancer (252)
Psychedelics (58)
Radiopharmaceuticals (304)
Rare diseases (941)
Real estate (7233)
Recruiting (81)
Regulatory (28375)
Reports (68)
Research institute (2727)
Resumes & cover letters (605)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (263)
Series B (204)
Service/supplier (26)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4256)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (101)
The Weekly (119)
Vaccines (1162)
Venture capital (99)
Weight loss (479)
Women's health (92)
Worklife (22)
Date
Today (133)
Last 7 days (691)
Last 30 days (2268)
Last 365 days (32320)
2026 (3445)
2025 (32657)
2024 (37947)
2023 (42566)
2022 (53928)
2021 (58723)
2020 (57665)
2019 (51316)
2018 (39100)
2017 (36939)
2016 (37906)
2015 (43930)
2014 (38619)
2013 (34718)
2012 (36735)
2011 (36753)
2010 (36373)
Location
Africa (1229)
Alabama (92)
Alaska (7)
Arizona (333)
Arkansas (14)
Asia (50150)
Australia (8633)
California (11713)
Canada (3353)
China (1193)
Colorado (500)
Connecticut (505)
Delaware (349)
Europe (114231)
Florida (1724)
Georgia (375)
Hawaii (4)
Idaho (67)
Illinois (957)
India (71)
Indiana (551)
Iowa (24)
Japan (441)
Kansas (132)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1466)
Massachusetts (8616)
Michigan (355)
Minnesota (667)
Mississippi (6)
Missouri (142)
Montana (36)
Nebraska (29)
Nevada (127)
New Hampshire (85)
New Jersey (3152)
New Mexico (33)
New York (3089)
North Carolina (1626)
North Dakota (10)
Northern California (5633)
Ohio (358)
Oklahoma (23)
Oregon (53)
Pennsylvania (2338)
Puerto Rico (25)
Rhode Island (50)
South America (1593)
South Carolina (67)
South Dakota (1)
Southern California (4527)
Tennessee (179)
Texas (1837)
United States (42146)
Utah (351)
Vermont (1)
Virginia (293)
Washington D.C. (88)
Washington State (981)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
846,176 Results for "hi tech pharmacal co".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Makary Got His Man in Pazdur—But Can He Last as CDER Director?
A week into his tenure as head of the FDA’s Center for Drug Evaluation and Research, experts agree that Rick Pazdur is the “ideal fit” to stabilize the agency. And, according to one ex-FDA official, if his CBER counterpart Vinay Prasad tries to supersede Pazdur’s authority, “there will be hell to pay.”
November 18, 2025
·
6 min read
·
Heather McKenzie
Regulatory
Marks Finds His Next Role as Lilly Snags Another Former FDA Regulator
Six months after his controversial departure from the top spot at the FDA’s biologics division, Peter Marks has landed at Eli Lilly, joining former colleague Rachael Anatol, who was ousted from the agency not long after Marks.
October 7, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Battelle Named Key Subcontractor to SA-TECH for Mission Support Services Contract at U.S. Army Dugway Proving Ground
January 30, 2026
·
3 min read
Press Releases
Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma
December 4, 2025
·
4 min read
IN PARTNERSHIP WITH PII
Thoughtful Tech: How Removing Technological Burdens Can Improve Clinical Trial Compliance and Patient Experience
In this episode presented by PII, BioSpace’s head of insights discusses how to relieve clinical trial patients of technological burden to improve compliance with guests Oliver Eden and Travis Webb.
November 6, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Guerbet: Appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee
December 19, 2025
·
2 min read
Press Releases
CellRight Tech: Private Equity Funding Secured
January 7, 2026
·
2 min read
Press Releases
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
December 29, 2025
·
4 min read
Press Releases
GLG Life Tech Corporation Reports 2025 Third Quarter Financial Results
November 27, 2025
·
23 min read
Drug Development
Hi-Tech Pharmaceuticals Phase Two Launch of Revolutionary PRO IGF-1® -- The First Successful Production of Actual IGF-1 In A Dietary Supplement
Hi-Tech Pharmaceuticals moves into its Phase two launch of PRO IGF-1®.
June 26, 2024
·
3 min read
1 of 84,618
Next
